Skip to Content

Zoledronic Acid

In the US, Zoledronic Acid (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis, Paget's Disease and Prevention of Osteoporosis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Bone resorption inhibitor

Treatment of hypercalcemia

Treatment of osteoporosis

Treatment of Paget's disease

Adjunct to antineoplastic therapy

Chemical Names

(1-Hydroxy-2-imidazol-1-yletylidene)diphosphonic acid (WHO)

Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)etylidene]bis-

Foreign Names

  • Acidum zoledronicum (Latin)
  • Zoledronsaeure (German)
  • Acide zolédronique (French)
  • Acido zoledronico (Spanish)

Generic Names

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.